Biomarck Pharmaceuticals, Ltd. is a clinical stage biotechnology company focused on treating patients with inflammatory and immunological diseases, using our platform of patent-protected peptides that have been developed to inhibit MARCKS. As a critical component of the inflammatory process, MARCKS is responsible for neutrophil aggregation at the site of inflammation and cytokine release.
Looking for a particular Biomarck Pharmaceuticals, Ltd. employee's phone or email?
The Biomarck Pharmaceuticals, Ltd. annual revenue was $14 million in 2026.
Rajin Ahuja is the Chairman of the Board of Biomarck Pharmaceuticals, Ltd..
5 people are employed at Biomarck Pharmaceuticals, Ltd..
Biomarck Pharmaceuticals, Ltd. is based in Durham, North Carolina.
The NAICS codes for Biomarck Pharmaceuticals, Ltd. are [3254, 325, 32541, 32].
The SIC codes for Biomarck Pharmaceuticals, Ltd. are [28, 283].